- Corporate Officers - G
- Giordano Natasha
Insider Trading History of Giordano Natasha
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Giordano Natasha since 2014.
This trader's CIK number is 1315585.
At the time of last reporting, Giordano Natasha was the Chief Executive Officer of Plx Pharma Inc.. (stock ticker symbol PLXP).
Also see all insider trading activities at Plx Pharma Inc..
Note that in the past
Giordano Natasha also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Plx Pharma Inc. (PLXP) by Giordano Natasha
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | PLXP | 4,100 | $14,977 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aceto Corp (ACET) by Giordano Natasha
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | ACET | 0 | $0 | 2,164 | $45,281 | 0 | $0 |
2014 | ACET | 0 | $0 | 6,000 | $111,922 | 0 | $0 |
Insider trading activities at 2 companies by Giordano Natasha:
1. Plx Pharma Inc. (PLXP)
2. Aceto Corp (ACET)
Table 1. Insider trading of Plx Pharma Inc. (PLXP) by Giordano Natasha
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-03-15 | PLXP | Buy | 4,100 | 3.65 | 14,977 |
Table 2. Insider trading of Aceto Corp (ACET) by Giordano Natasha
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-03-04 | ACET | Sale | 2,164 | 20.93 | 45,281 |
2014-09-09 | ACET | Sale | 1,453 | 21.94 | 31,878 |
2014-06-06 | ACET | Sale | 1,160 | 17.28 | 20,044 |
2014-06-02 | ACET | Sale | 1,149 | 17.43 | 20,029 |
2014-05-23 | ACET | Sale | 1,128 | 17.91 | 20,202 |
2014-05-21 | ACET | Sale | 1,110 | 17.81 | 19,769 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Giordano Natasha
(Chief Executive Officer of Plx Pharma Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.